Back to Search
MARTIN MARON, MD
MD
Cardiovascular Disease Physician
NPI: 1225146905IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
213784(MA)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Additional
Education
TULANE UNIVERSITY SCHOOL OF MEDICINE
Class of 1999
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Effect of Spironolactone on Myocardial Fibrosis and Other Clinical Variables in Patients with Hypertrophic Cardiomyopathy.
PMID 29604289·Am J Med·2018
2-rct
Prognostic Value of LGE-CMR in HCM: A Meta-Analysis.
PMID 27450876·JACC Cardiovasc Imaging·2016
1-meta
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.
PMID 25406305·Circulation·2015
4-observational
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.
PMID 25092278·Circulation·2014
4-observational
Spironolactone for heart failure with preserved ejection fraction.
PMID 25006726·N Engl J Med·2014
8-other
Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.
PMID 24998133·J Am Coll Cardiol·2014
6-review
Angiotensin-converting-enzyme inhibition in stable coronary artery disease.
PMID 15531767·N Engl J Med·2004
3-trial
Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis.
PMID 15313958·Circulation·2004
8-other
Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.
PMID 14993121·Circulation·2004
7-preclinical
Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
PMID 14517164·Circulation·2003
3-trial
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
PMID 12668699·N Engl J Med·2003
3-trial
Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy.
PMID 11171784·Circulation·2001
7-preclinical
Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators.
PMID 11094035·Circulation·2000
3-trial
Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death.
PMID 10636256·J Am Coll Cardiol·2000
8-other
Beta-adrenoceptor stimulation of alveolar fluid clearance is increased in rats with heart failure.
PMID 19592457·Am J Physiol Lung Cell Mol Physiol·2009
7-preclinical
Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
PMID 19589434·J Am Coll Cardiol·2009
8-other
Managing trade-offs in landscape restoration and revegetation projects.
PMID 19263896·Ecol Appl·2008
7-preclinical
Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
PMID 18809796·Circulation·2008
8-other
Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.
PMID 17088454·Circulation·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 800 WASHINGTON ST
BOSTON, MA 02111 - Phone
- (617) 636-5000
Quick Facts
- NPI
- 1225146905
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 27
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile